weight loss surgery vs glp-1 Choosing Between Medications and Bariatric Bariatric surgery vs GLP1: WVU

Oral Biol

The FDA prescribing information for Vyleesi provides clinicians and patients with precisely characterized cardiovascular effects (peak systolic elevation of ~6 mmHg at 24 hours post-dose, returning to baseline within 12 hours), documented contraindications (uncontrolled hypertension, known cardiovascular disease), and management strategies for nausea (ondansetron 30 minutes pre-dose)

Endocrine Rev 20:876913 Adrian TE, Ferri GL, Bacarese-Hamilton AJ et al

24-29 (An oral GLP-1 receptor agonist is currently in clinical development.) Table 6 provides a summary of dosing recommendations for currently available GLP-1 receptor agonists